CIK 0001835579 · <br>Emerging growth company
ImageneBio, Inc.
Sign in to watch- Ticker
- IMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811697316
- Phone
- 857-343-8292
- Business address
- 12526 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Former names
- Ikena Oncology, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | Grant-Huerta Yanina Chief Financial Officer | Grant or award | +65,000 | 65,000 | ||
| 2026-08-14 | Grant-Huerta Yanina Chief Financial Officer | Grant or award | +39,000 | 104,000 | ||
| 2026-08-14 | Grant-Huerta Yanina Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +56,000 | 56,000 | ||
| 2026-08-14 | Yarema Kristin Chief Executive Officer | Grant or award | +254,800 | 493,705 | ||
| 2026-08-14 | Yarema Kristin Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +137,200 | 137,200 | ||
| 2026-08-14 | Yarema Kristin Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-07-25 | Yarema Kristin Chief Executive Officer | Option exercise | +38,376 | 123,776 | ||
| 2026-07-25 | Yarema Kristin Chief Executive Officer | Other acquisition | +115,129 | 238,905 | ||
| 2026-07-25 | Yarema Kristin Chief Executive Officer | Option exercise · Restricted Stock Units | −38,376 | 115,129 | ||
| 2026-07-25 | Yarema Kristin Chief Executive Officer | Other disposition · Restricted Stock Units | −115,129 | 0 | ||
| 2026-07-17 | Lally Robert B Principal Accounting Officer | Sale | −1,525 | $5.34 | $8K | 55,582 |
| 2026-07-16 | Lally Robert B Principal Accounting Officer | Sale | −1,671 | $5.50 | $9K | 57,107 |
| 2026-06-16 | Bonita David P Director | Grant or award · Stock Option (right to buy) | +15,600 | 15,600 | ||
| 2026-06-16 | Wang Jonathan Jian Director | Grant or award · Stock Option (right to buy) | +15,600 | 15,600 | ||
| 2026-06-16 | Stampacchia Otello Director | Grant or award · Stock Option (right to buy) | +15,600 | 15,600 | ||
| 2026-06-16 | SLATTERY JOSEPH P Director | Grant or award · Stock Option (right to buy) | +15,600 | 15,600 | ||
| 2026-04-14 | Bonita David P Director | Purchase · Pre-Funded Warrants (right to buy) | +336,603 | 336,603 | ||
| 2026-04-14 | Bonita David P Director | Purchase · Pre-Funded Warrants (right to buy) | +384,689 | 384,689 | ||
| 2026-04-14 | ORBIMED ADVISORS LLC Director | Purchase · Pre-Funded Warrants (right to buy) | +336,603 | 336,603 | ||
| 2026-04-14 | ORBIMED ADVISORS LLC Director | Purchase · Pre-Funded Warrants (right to buy) | +384,689 | 384,689 |
Page 1 of 12 · 222 trades